Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | CYP39A1 |
| Upstream (Parents) |
|---|
| (<<) ZGPAT → CYP39A1 |
| (<<) GBA3 → CYP39A1 |
| (<<) APOM → CYP39A1 |
| Downstream (Children) |
|---|
| CYP39A1 → PRRG4 (>>) |
| CYP39A1 → HTR1A (>>) |
| CYP39A1 → LIME1 (>>) |
| CYP39A1 → PLXNB1 (>>) |
| CYP39A1 → AMFR (>>) |
| CYP39A1 → TBX3 (>>) |
| CYP39A1 → NPY2R (>>) |
| CYP39A1 → IL1F7 (>>) |
| CYP39A1 → RGS10 (>>) |
| CYP39A1 → IRF2BP1 (>>) |
| CYP39A1 → LRP3 (>>) |
| CYP39A1 → PLAGL1 (>>) |
